Does estrogen have any real effect on voiding dysfunction in women?

Current Urology Reports

Volumn 12, Issue 5, 2011, Pages 345-350

  Koski, Michelle E ^a   Chermansky, Christopher J ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Estrogen; Hormone replacement; Overactive bladder; Postmenopause; Stress urinary incontinence; Urge urinary incontinence; Urinary tract infection; Voiding dysfunction; Women's health

Indexed keywords

CAVEOLIN 1; CONJUGATED ESTROGEN; ESTRADIOL; ESTRADIOL ACETATE; ESTRADIOL VALERATE; ESTRIOL; ESTROGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO;

ARTICLE; DRUG DOSAGE FORM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG MECHANISM; ESTROGEN THERAPY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MICTURITION DISORDER; NONHUMAN; OVERACTIVE BLADDER; POSTMENOPAUSE; PROTEIN EXPRESSION; RECURRENT INFECTION; STRESS INCONTINENCE; URGE INCONTINENCE; URINARY TRACT INFECTION; URINE INCONTINENCE; VAGINA ATROPHY; VAGINA BLEEDING; VAGINAL HYSTERECTOMY; WOMEN'S HEALTH;

ESTROGENS; FEMALE; HUMANS; RECURRENCE; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE, URGE; URINARY TRACT INFECTIONS; URINATION DISORDERS;

EID: 80755128428     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-011-0208-y     Document Type: Article

References (36)

1. P Blakeman P Hilton 1996 Cellular and molecular biology in urogynaecology Curr Opin Obstet Gynecol. 8 357 360 8941434 1:STN:280:DyaK2s%2Fps1CrsQ%3D%3D (Pubitemid 26384380)
2. CS Iosif Z Bekassy 1984 Prevalence of genito-urinary symptoms in the late menopause Acta Obstet Gynecol Scand. 63 257 260 6730943 10.3109/ 00016348409155509 1:STN:280:DyaL2c3islWrtQ%3D%3D (Pubitemid 14149172)
3. T Hillard 2010 The postmenopausal bladder Menopause Int 16 74 80 20729499 10.1258/mi.2010.010020 This review article addresses the basis for the effects of estrogen on the postmenopausal urinary tract
4. Durham E. Understanding alternatives for estrogen preparations. Endocrine Today. 2009;7 Epub 2009 April1.
5. AL Smith AJ Wein 2010 Estrogen replacement therapy for the treatment of postmenopausal genitourinary tract dysfunction Discov Med 10 55 500 510 21189221 This recent comprehensive review article discusses the basis and effect of systemic and local estrogen on postmenopausal urinary symptoms
6. Drug Facts and Comparisons. St Louis. MO: Wolters Kluwer Health; 2011.
7. CY Long CM Liu HC Hsu, et al. 2006 A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women Menopause. 13 737 743 16946685 10.1097/01.gme.0000227401.98933.0b (Pubitemid 44435028)
8. L Cardozo H Rekers A Tapp, et al. 1993 Oestriol in the treatment of postmenopausal urgency: a multicentre study Maturitas. 18 47 53 8107615 10.1016/0378-5122(93)90028-G 1:STN:280:DyaK2c7ltVeluw%3D%3D (Pubitemid 24037142)
9. D Robinson LD Cardozo 2003 The role of estrogens in female lower urinary tract dysfunction Urology. 62 45 51 14550837 10.1016/S0090-4295(03)00676-9 (Pubitemid 41116582)
10. J Rufford A Hextall L Cardozo, et al. 2003 A double-blind placebo-controlled trial on the effects of 25 mg estradiol implants on the urge syndrome in postmenopausal women Int Urogynecol J Pelvic Floor Dysfunct. 14 78 83 12851747 10.1007/s00192-003-1054-3 (Pubitemid 36986906)
11. JS Brown D Grady JG Ouslander, et al. 1999 Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group Obstet Gynecol 94 66 70 10389720 10.1016/S0029-7844(99)00263-X 1:STN:280:DyaK1Mzhs1GrsA%3D%3D (Pubitemid 29284428)
12. D Grady JS Brown E Vittinghoff, et al. 2001 Postmenopausal hormones and incontinence: the heart and estrogen/progestin replacement study Obstet Gynecol. 97 116 120 11152919 10.1016/S0029-7844(00)01115-7 1:CAS:528: DC%2BD3MXitlyjug%3D%3D This post-hoc analysis of women from the original RCT assessing the effect of daily estrogen/progestin on coronary events found that both UUI and SUI worsened with HT (Pubitemid 32057168)
13. MJ Stampfer GA Colditz WC Willett, et al. 1991 Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study N Engl J Med. 325 756 762 1870648 10.1056/NEJM199109123251102 1:STN:280:DyaK3MzjtlKqtg%3D%3D
14. F Grodstein K Lifford NM Resnick, et al. 2004 Postmenopausal hormone therapy and risk of developing urinary incontinence Obstet Gynecol. 103 254 260 14754692 10.1097/01.AOG.0000107290.33034.6f 1:CAS:528:DC%2BD2cXhslGgu7o%3D
15. MK Townsend GC Curhan NM Resnick, et al. 2009 Postmenopausal hormone therapy and incident urinary incontinence in middle-aged women Am J Obstet Gynecol 200 86 e1 5 19019333
16. L Cardozo G Lose D McClish, et al. 2004 A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder Acta Obstet Gynecol Scand. 83 892 897 15453881 (Pubitemid 39331534)
17. B Moehrer A Hextall S Jackson 2003 Oestrogens for urinary incontinence in women Cochrane Database Syst Rev 2 CD001405 12804406
18. SL Hendrix BB Cochrane IE Nygaard, et al. 2005 Effects of estrogen with and without progestin on urinary incontinence JAMA 293 935 948 15728164 10.1001/jama.293.8.935 1:CAS:528:DC%2BD2MXhsFCgt7Y%3D This excellent subset analysis of postmenopausal women followed in the WHI study found that HT increased the incidence of both UUI and SUI after 1 year, although the risk was much higher for SUI. (Pubitemid 40271125)
19. CE DuBeau 2005 Estrogen treatment for urinary incontinence: never, now, or in the future? JAMA. 293 998 1001 15728171 10.1001/jama.293.8.998 1:CAS:528:DC%2BD2MXhsFGhu7s%3D This well-written editorial comment to the WHI subset analysis by Hendrix et al addresses limitations of the conclusions reached in that study (Pubitemid 40271132)
20. JS Brown LM Nyberg JW Kusek, et al. 2003 Proceedings of the national institute of diabetes and digestive and kidney diseases international symposium on epidemiologic issues in urinary incontinence in women Am J Obstet Gynecol. 188 S77 S88 12825024 10.1067/mob.2003.353 (Pubitemid 36741312)
21. J Suckling A Lethaby R Kennedy 2006 Local oestrogen for vaginal atrophy in postmenopausal women Cochrane Database Syst Rev 4 CD001500 17054136
22. SO Kim SH Song SC Lee, et al. 2011 Effects of estrogens on the expression of caveolin-1 in the urinary bladders of female rats Int Neurourol J 15 13 18 21468281 10.5213/inj.2011.15.1.13 This interesting basic-science paper demonstrated that estrogen reversed bladder overactivity in rats and restored caveolin-1, suggesting that estrogen might improve OAB and UUI by increasing caveolin-1 within the bladder
23. HH Lai TB Boone TC Thompson, et al. 2007 Using caveolin-1 knockout mouse to study impaired detrusor contractility and disrupted muscarinic activity in the aging bladder Urology. 69 407 411 17320698 10.1016/j.urology.2006.12.018 (Pubitemid 46274959)
24. • Andersson KE, Chapple CR, Cardozo L, et al. Pharmacological treatment of urinary incontinence. In: Abrams P, Cardozo L, Khoury S, and Wein A, editors. Incontinence. Paris: Health Publication Ltd; 2009. pp. 676-78. This concise and excellent review of estrogen treatment for UI by the ICI gave estrogen use a grade C for UUI and a grade D for SUI.
25. T Rud KE Andersson M Asmussen, et al. 1980 Factors maintaining the intraurethral pressure in women Invest Urol 17 343 347 7188694 1:STN:280:DyaL3c%2FptlyrtA%3D%3D (Pubitemid 10103147)
26. S Sorensen 1988 Urodynamic investigations and their reproducibility in healthy postmenopausal females Scand J Urol Nephrol Suppl. 114 42 47 3201167 1:STN:280:DyaL1M%2Fnt1GrsA%3D%3D
27. NN Bhatia A Bergman MM Karram 1989 Effects of estrogen on urethral function in women with urinary incontinence Am J Obstet Gynecol. 160 176 181 2912080 1:STN:280:DyaL1M7gtleltA%3D%3D (Pubitemid 19055284)
28. st report from the HUT committee showed that estrogen treatment in postmenopausal women with SUI had no effect on the volume of urine lost (Pubitemid 24027373)
29. S Jackson A Shepherd S Brookes, et al. 1999 The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial Br J Obstet Gynaecol. 106 711 718 10428529 10.1111/j.1471-0528.1999.tb08372.x 1:CAS:528:DyaK1MXkvFKlur0%3D (Pubitemid 29304395)
30. A Al-Badr S Ross D Soroka, et al. 2003 What is the available evidence for hormone replacement therapy in women with stress urinary incontinence? J Obstet Gynaecol Can. 25 567 574 12851668 This meta-analysis concluded that the current literature does not support the use of estrogen for SUI
31. TA Stamey MF Kaufman 1975 Studies of introital colonization in women with recurrent urinary infections. II. A comparison of growth in normal vaginal fluid of common versus uncommon serogroups of Escherichia coli J Urol. 114 264 267 240039 1:STN:280:DyaE28%2Fgslyhsw%3D%3D
32. L Cardozo G Bachmann D McClish, et al. 1998 Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the hormones and urogenital therapy committee Obstet Gynecol. 92 722 727 9764689 10.1016/S0029-7844(98)00175-6 1:STN:280:DyaK1cvjsFOiug%3D%3D (Pubitemid 28440818)
33. R Raz WE Stamm 1993 A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections N Engl J Med. 329 753 756 8350884 10.1056/NEJM199309093291102 1:STN:280:DyaK3szlsVequg%3D%3D (Pubitemid 23262529)
34. B Eriksen 1999 A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women Am J Obstet Gynecol. 180 1072 1079 10329858 10.1016/S0002-9378(99)70597-1 1:CAS:528:DyaK1MXjvFeltL0%3D (Pubitemid 29258997)
35. rd report from the HUT committee is an excellent meta-analysis of the literature addressing the effect of estrogen on recurrent UTIs, and it showed that estrogen use reduced recurrent UTIs and that local (vaginal) estrogen was superior to systemic estrogen (Pubitemid 32219739)
36. C Perrotta M Aznar R Mejia, et al. 2008 Oestrogens for preventing recurrent urinary tract infection in postmenopausal women Cochrane Database Syst Rev 2 CD005131 18425910 This large meta-analysis (3345 patients in 9 studies) confirmed that vaginal estrogen is superior to oral estrogen in reducing recurrent UTIs